0067-2056Level 3
Excedrin PM Triple Action Caplets (Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate)
**Product type:** Human Otc Drug
**Active ingredient:** ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE
**Strength:** 250; 250; 38 mg/1; mg/1; mg/1
**Dosage form:** Tablet, Coated
**Route:** Oral
**Labeler:** Haleon US Holdings LLC
**Marketing category:** OTC MONOGRAPH DRUG (M013)
**Pharmacologic class:** Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0067-2056Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.